Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis

INTRODUCTION: Pain control is one of the most important aspects of rheumatoid arthritis (RA) management from the patient’s perspective. Newer generations of RA treatment including tumor necrosis factor inhibitor (TNFi) have the potential to alleviate pain and thus reduce opioid utilization. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Siyeon, Le, Tham T., Slejko, Julia F., Villalonga-Olives, Ester, Onukwugha, Eberechukwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858479/
https://www.ncbi.nlm.nih.gov/pubmed/31628617
http://dx.doi.org/10.1007/s40744-019-00175-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858479/
https://www.ncbi.nlm.nih.gov/pubmed/31628617
http://dx.doi.org/10.1007/s40744-019-00175-6

Ejemplares similares